Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Other Working Capital Changes (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Other Working Capital Changes for 6 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes fell 22.45% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 70.34% decrease, with the full-year FY2025 number at $1.1 million, down 70.34% from a year prior.
  • Other Working Capital Changes was $1.1 million for Q4 2025 at PROCEPT BioRobotics, up from -$1.2 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $7.2 million in Q4 2023 to a low of -$4.4 million in Q3 2023.
  • A 5-year average of $581850.0 and a median of $495500.0 in 2022 define the central range for Other Working Capital Changes.
  • Biggest YoY gain for Other Working Capital Changes was 1302.93% in 2023; the steepest drop was 990.96% in 2023.
  • PROCEPT BioRobotics' Other Working Capital Changes stood at -$606000.0 in 2021, then soared by 184.49% to $512000.0 in 2022, then skyrocketed by 1302.93% to $7.2 million in 2023, then plummeted by 80.22% to $1.4 million in 2024, then fell by 22.45% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Other Working Capital Changes are $1.1 million (Q4 2025), -$1.2 million (Q3 2025), and $770000.0 (Q2 2025).